ARCHIVES

Radioactive Seeds Tested In Treatment Of NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

ODAC Member Critical Of Amgen For Price Incentives.

March 21, 2008

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

In Brief: Loberg Resigns From Bristol-Myers Squibb; Bloomfield Heads Cancer Center At Ohio State

February 14, 1997

NCI Cooperative Group, Cancer Center Trials Listed

July 27, 2007

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013